Page last updated: 2024-11-02

pd 98059 and Spondylitis, Ankylosing

pd 98059 has been researched along with Spondylitis, Ankylosing in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Spondylitis, Ankylosing: A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, Y1
Wang, D1
Li, F1
Shi, G1

Other Studies

1 other study available for pd 98059 and Spondylitis, Ankylosing

ArticleYear
Gαq controls rheumatoid arthritis via regulation of Th17 differentiation.
    Immunology and cell biology, 2015, Volume: 93, Issue:7

    Topics: Animals; Arthritis, Rheumatoid; CD4-Positive T-Lymphocytes; Dendritic Cells; Flavonoids; Gene Expres

2015